"Myeloma Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal immunoglobulins characteristic of MULTIPLE MYELOMA.
| Descriptor ID |
D009194
|
| MeSH Number(s) |
D12.776.124.486.485.900.500 D12.776.124.790.651.900.500 D12.776.377.715.548.900.500 D12.776.624.553
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myeloma Proteins".
Below are MeSH descriptors whose meaning is more specific than "Myeloma Proteins".
This graph shows the total number of publications written about "Myeloma Proteins" by people in this website by year, and whether "Myeloma Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myeloma Proteins" by people in Profiles.
-
Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myeloma. Br J Haematol. 2004 May; 125(4):470-6.
-
Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003 Jun; 121(5):749-57.
-
IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity. 2001 Mar; 14(3):277-89.
-
Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol. 1999 Sep; 52(3):245-9.
-
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998 Jul 15; 41(5):1063-7.
-
A Vh region synthetic peptide induces antibodies which bind native immunoglobulins and augment an immune response to antigen. Adv Exp Med Biol. 1989; 251:129-43.
-
CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production. Cell Immunol. 1988 Jul; 114(2):257-71.
-
Antibody combining sites can be mimicked synthetically. Surface-simulation synthesis of the phosphorylcholine-combining site of myeloma protein M-603. Biochem J. 1980 Jun 01; 187(3):661-6.
-
Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J Chronic Dis. 1971 Jul; 24(4):221-7.